Difference between revisions of "Research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/members"
Jump to navigation
Jump to search
(Marked this version for translation) |
|||
| (6 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
| − | ==Cancer Moonshot℠ Blue Ribbon Panel Members== | + | <languages/> |
| + | <translate> | ||
| + | ==Cancer Moonshot℠ Blue Ribbon Panel Members== <!--T:1--> | ||
| + | <!--T:2--> | ||
[[File:Blue-ribbon-panel-thumb.jpg|200px|right]] | [[File:Blue-ribbon-panel-thumb.jpg|200px|right]] | ||
| + | <!--T:3--> | ||
The Blue Ribbon Panel is composed of leading experts from a broad range of scientific areas, including biology, immunology, genomics, diagnostics, bioinformatics, and cancer prevention and treatment. Members also include investigators with expertise in clinical trials and cancer health disparities, as well as representatives of cancer advocacy groups and pharmaceutical and biotechnology companies. | The Blue Ribbon Panel is composed of leading experts from a broad range of scientific areas, including biology, immunology, genomics, diagnostics, bioinformatics, and cancer prevention and treatment. Members also include investigators with expertise in clinical trials and cancer health disparities, as well as representatives of cancer advocacy groups and pharmaceutical and biotechnology companies. | ||
| + | <!--T:4--> | ||
The members of the Blue Ribbon Panel are: | The members of the Blue Ribbon Panel are: | ||
| − | :Tyler Jacks, Ph.D. (Co-Chair) | + | <!--T:5--> |
| − | + | :'''Tyler Jacks, Ph.D. (Co-Chair)''' | |
:Chair, National Cancer Advisory Board | :Chair, National Cancer Advisory Board | ||
:Director, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology | :Director, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology | ||
| − | :Elizabeth Jaffee, M.D. (Co-Chair) | + | <!--T:6--> |
| + | :'''Elizabeth Jaffee, M.D. (Co-Chair)''' | ||
:Professor and Deputy Director for Translational Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine | :Professor and Deputy Director for Translational Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine | ||
| − | :Dinah Singer, Ph.D. (Co-Chair and Designated Federal Official) | + | <!--T:7--> |
| + | :'''Dinah Singer, Ph.D. (Co-Chair and Designated Federal Official)''' | ||
:Acting Deputy Director, National Cancer Institute | :Acting Deputy Director, National Cancer Institute | ||
:Director, Division of Cancer Biology, National Cancer Institute | :Director, Division of Cancer Biology, National Cancer Institute | ||
| − | :Peter Adamson, M.D. | + | <!--T:8--> |
| + | :'''Peter Adamson, M.D.''' | ||
:Professor and Director, Experimental Therapeutics in Oncology, The Children’s Hospital of Philadelphia | :Professor and Director, Experimental Therapeutics in Oncology, The Children’s Hospital of Philadelphia | ||
| − | :James Allison, Ph.D. | + | <!--T:9--> |
| + | :'''James Allison, Ph.D.''' | ||
:Professor and Chair of Immunology, University of Texas MD Anderson Cancer Center | :Professor and Chair of Immunology, University of Texas MD Anderson Cancer Center | ||
| − | :David Arons, J.D. | + | <!--T:10--> |
| + | :'''David Arons, J.D.''' | ||
:Chief Executive Officer, National Brain Tumor Society | :Chief Executive Officer, National Brain Tumor Society | ||
| − | :Mary Beckerle, Ph.D. | + | <!--T:11--> |
| + | :'''Mary Beckerle, Ph.D.''' | ||
:Chief Executive Officer and Director, Huntsman Cancer Institute, University of Utah | :Chief Executive Officer and Director, Huntsman Cancer Institute, University of Utah | ||
| − | :Mitch Berger, M.D. | + | <!--T:12--> |
| + | :'''Mitch Berger, M.D.''' | ||
:Professor and Chair, Department of Neurological Surgery, University of California, San Francisco | :Professor and Chair, Department of Neurological Surgery, University of California, San Francisco | ||
| − | :Jeff Bluestone, Ph.D. | + | <!--T:13--> |
| + | :'''Jeff Bluestone, Ph.D.''' | ||
:A.W. and Mary Margaret Clausen Distinguished Professor of Metabolism and Endocrinology, University of California, San Francisco | :A.W. and Mary Margaret Clausen Distinguished Professor of Metabolism and Endocrinology, University of California, San Francisco | ||
| − | :Chi Van Dang, M.D., Ph.D. | + | <!--T:14--> |
| + | :'''Chi Van Dang, M.D., Ph.D.''' | ||
:Scientific Director, Ludwig Cancer Research | :Scientific Director, Ludwig Cancer Research | ||
| − | :Mikael Dolsten, M.D., Ph.D. | + | <!--T:15--> |
| + | :'''Mikael Dolsten, M.D., Ph.D.''' | ||
:President, Pfizer Worldwide Research and Development | :President, Pfizer Worldwide Research and Development | ||
:Executive Vice President, Pfizer, Inc. | :Executive Vice President, Pfizer, Inc. | ||
| − | :James Downing, M.D. | + | <!--T:16--> |
| + | :'''James Downing, M.D.''' | ||
:President and Chief Executive Officer, St. Jude Children’s Research Hospital | :President and Chief Executive Officer, St. Jude Children’s Research Hospital | ||
| − | :Levi Garraway, M.D., Ph.D. | + | <!--T:17--> |
| + | :'''Levi Garraway, M.D., Ph.D.''' | ||
:Senior Vice President, Global Development and Medical Affairs, Lilly Oncology, Eli Lilly and Company | :Senior Vice President, Global Development and Medical Affairs, Lilly Oncology, Eli Lilly and Company | ||
| − | :Gad Getz, Ph.D. | + | <!--T:18--> |
| + | :'''Gad Getz, Ph.D.''' | ||
:Director of Cancer Genome Computational Analysis Group and Institute Member, Broad Institute of MIT and Harvard | :Director of Cancer Genome Computational Analysis Group and Institute Member, Broad Institute of MIT and Harvard | ||
:Director, Bioinformatics Program, Massachusetts General Hospital Cancer Center and Department of Pathology | :Director, Bioinformatics Program, Massachusetts General Hospital Cancer Center and Department of Pathology | ||
| Line 56: | Line 74: | ||
:Paul C. Zamecnik Chair in Oncology, MGH Cancer Center | :Paul C. Zamecnik Chair in Oncology, MGH Cancer Center | ||
| − | :Laurie Glimcher, M.D. | + | <!--T:19--> |
| + | :'''Laurie Glimcher, M.D.''' | ||
:Professor of Medicine and Stephen and Suzanne Weiss Dean, Weill Cornell Medical College | :Professor of Medicine and Stephen and Suzanne Weiss Dean, Weill Cornell Medical College | ||
:Incoming President and Chief Executive Officer, Dana-Farber Cancer Institute | :Incoming President and Chief Executive Officer, Dana-Farber Cancer Institute | ||
| − | :Lifang Hou, M.D., Ph.D. | + | <!--T:20--> |
| + | :'''Lifang Hou, M.D., Ph.D.''' | ||
:Associate Professor of Preventive Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine | :Associate Professor of Preventive Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine | ||
| − | :Neal Kassell, M.D. | + | <!--T:21--> |
| + | :'''Neal Kassell, M.D.''' | ||
:Chairman, Focused Ultrasound Foundation | :Chairman, Focused Ultrasound Foundation | ||
:Professor of Neurosurgery, University of Virginia | :Professor of Neurosurgery, University of Virginia | ||
| − | :María Elena Martínez, Ph.D. | + | <!--T:22--> |
| + | :'''María Elena Martínez, Ph.D.''' | ||
:Sam M. Walton Endowed Chair for Cancer Research, Professor of Family Medicine and Public Health, and Co-director of the Reducing :Cancer Disparities Program, UC San Diego Moores Cancer Center | :Sam M. Walton Endowed Chair for Cancer Research, Professor of Family Medicine and Public Health, and Co-director of the Reducing :Cancer Disparities Program, UC San Diego Moores Cancer Center | ||
| − | :Deborah Mayer, Ph.D., R.N. | + | <!--T:23--> |
| + | :'''Deborah Mayer, Ph.D., R.N.''' | ||
:Professor of Adult and Geriatric Health, University of North Carolina School of Nursing | :Professor of Adult and Geriatric Health, University of North Carolina School of Nursing | ||
:Director of Cancer Survivorship, UNC Lineberger Comprehensive Cancer Center | :Director of Cancer Survivorship, UNC Lineberger Comprehensive Cancer Center | ||
| − | :Edith Mitchell, M.D., F.A.C. | + | <!--T:24--> |
| + | :'''Edith Mitchell, M.D., F.A.C.P''' | ||
:Professor of Medical Oncology and Associate Director for Diversity Services, Sidney Kimmel Cancer Center at Thomas Jefferson University | :Professor of Medical Oncology and Associate Director for Diversity Services, Sidney Kimmel Cancer Center at Thomas Jefferson University | ||
| − | :Augusto Ochoa, M.D. | + | <!--T:25--> |
| + | :'''Augusto Ochoa, M.D.''' | ||
:Professor of Pediatrics and Director, Stanley S. Scott Cancer Center, Louisiana State University | :Professor of Pediatrics and Director, Stanley S. Scott Cancer Center, Louisiana State University | ||
| − | : | + | <!--T:26--> |
| + | :Je'''nnifer Pietenpol, Ph.D.''' | ||
:Benjamin F. Byrd, Jr. Professor of Oncology, Professor of Biochemistry, and Director, Vanderbilt-Ingram Cancer Center | :Benjamin F. Byrd, Jr. Professor of Oncology, Professor of Biochemistry, and Director, Vanderbilt-Ingram Cancer Center | ||
| − | :Angel Pizarro, M.S.E. | + | <!--T:27--> |
| + | :'''Angel Pizarro, M.S.E.''' | ||
:Technical Business Development Manager, Amazon Web Services Scientific Computing and Research Computing | :Technical Business Development Manager, Amazon Web Services Scientific Computing and Research Computing | ||
| − | :Barbara Rimer, Dr.P.H. | + | <!--T:28--> |
| + | :'''Barbara Rimer, Dr.P.H.''' | ||
:Alumni Distinguished Professor and Dean, University of North Carolina Gillings School of Global Public Health | :Alumni Distinguished Professor and Dean, University of North Carolina Gillings School of Global Public Health | ||
| − | :Charles Sawyers, M.D. | + | <!--T:29--> |
| + | :'''Charles Sawyers, M.D.''' | ||
:Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center | :Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center | ||
:Investigator, Howard Hughes Medical Institute | :Investigator, Howard Hughes Medical Institute | ||
| − | + | <!--T:30--> | |
| + | :'''Ellen Sigal, Ph.D.''' | ||
:Founder and Chair, Friends of Cancer Research | :Founder and Chair, Friends of Cancer Research | ||
| − | :Patrick Soon-Shiong, M.D., FRCS (C), | + | <!--T:31--> |
| + | :'''Patrick Soon-Shiong, M.D., FRCS (C), FACS''' | ||
:Founder, Chair, and CEO, NantWorks LLC | :Founder, Chair, and CEO, NantWorks LLC | ||
| − | :Wai-Kwan Alfred Yung, M.D. | + | <!--T:32--> |
| + | :'''Wai-Kwan Alfred Yung, M.D.''' | ||
:Professor of Neuro-Oncology and Chair of Clinical Cancer Care, University of Texas MD Anderson Cancer Center | :Professor of Neuro-Oncology and Chair of Clinical Cancer Care, University of Texas MD Anderson Cancer Center | ||
| − | |||
:Ex Officio members of the Blue Ribbon Panel are: | :Ex Officio members of the Blue Ribbon Panel are: | ||
| − | :David Atkins, M.D., M.P.H. | + | <!--T:33--> |
| + | :'''David Atkins, M.D., M.P.H.''' | ||
:Acting Chief Research and Development Officer, Department of Veterans Affairs | :Acting Chief Research and Development Officer, Department of Veterans Affairs | ||
| − | :Robert Califf, M.D. | + | <!--T:34--> |
| + | :'''Robert Califf, M.D.''' | ||
:Commissioner, U.S. Food and Drug Administration | :Commissioner, U.S. Food and Drug Administration | ||
| − | :Karen Guice, M.D., M.P.P. | + | <!--T:35--> |
| + | :'''Karen Guice, M.D., M.P.P.''' | ||
:Acting Assistant Secretary of Defense for Health Affairs, Department of Defense | :Acting Assistant Secretary of Defense for Health Affairs, Department of Defense | ||
| − | :Jason Paragas, Ph.D. | + | <!--T:36--> |
| + | :'''Jason Paragas, Ph.D.''' | ||
:Director of Innovation, Lawrence Livermore National Laboratory | :Director of Innovation, Lawrence Livermore National Laboratory | ||
| − | :Lawrence Tabak, D.D.S., Ph.D. | + | <!--T:37--> |
| + | :'''Lawrence Tabak, D.D.S., Ph.D.''' | ||
:Principal Deputy Director, National Institutes of Health | :Principal Deputy Director, National Institutes of Health | ||
| + | </translate> | ||
Latest revision as of 21:46, 29 October 2019
Cancer Moonshot℠ Blue Ribbon Panel Members
The Blue Ribbon Panel is composed of leading experts from a broad range of scientific areas, including biology, immunology, genomics, diagnostics, bioinformatics, and cancer prevention and treatment. Members also include investigators with expertise in clinical trials and cancer health disparities, as well as representatives of cancer advocacy groups and pharmaceutical and biotechnology companies.
The members of the Blue Ribbon Panel are:
- Tyler Jacks, Ph.D. (Co-Chair)
- Chair, National Cancer Advisory Board
- Director, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- Elizabeth Jaffee, M.D. (Co-Chair)
- Professor and Deputy Director for Translational Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
- Dinah Singer, Ph.D. (Co-Chair and Designated Federal Official)
- Acting Deputy Director, National Cancer Institute
- Director, Division of Cancer Biology, National Cancer Institute
- Peter Adamson, M.D.
- Professor and Director, Experimental Therapeutics in Oncology, The Children’s Hospital of Philadelphia
- James Allison, Ph.D.
- Professor and Chair of Immunology, University of Texas MD Anderson Cancer Center
- David Arons, J.D.
- Chief Executive Officer, National Brain Tumor Society
- Mary Beckerle, Ph.D.
- Chief Executive Officer and Director, Huntsman Cancer Institute, University of Utah
- Mitch Berger, M.D.
- Professor and Chair, Department of Neurological Surgery, University of California, San Francisco
- Jeff Bluestone, Ph.D.
- A.W. and Mary Margaret Clausen Distinguished Professor of Metabolism and Endocrinology, University of California, San Francisco
- Chi Van Dang, M.D., Ph.D.
- Scientific Director, Ludwig Cancer Research
- Mikael Dolsten, M.D., Ph.D.
- President, Pfizer Worldwide Research and Development
- Executive Vice President, Pfizer, Inc.
- James Downing, M.D.
- President and Chief Executive Officer, St. Jude Children’s Research Hospital
- Levi Garraway, M.D., Ph.D.
- Senior Vice President, Global Development and Medical Affairs, Lilly Oncology, Eli Lilly and Company
- Gad Getz, Ph.D.
- Director of Cancer Genome Computational Analysis Group and Institute Member, Broad Institute of MIT and Harvard
- Director, Bioinformatics Program, Massachusetts General Hospital Cancer Center and Department of Pathology
- Associate Professor of Pathology, Harvard Medical School
- Paul C. Zamecnik Chair in Oncology, MGH Cancer Center
- Laurie Glimcher, M.D.
- Professor of Medicine and Stephen and Suzanne Weiss Dean, Weill Cornell Medical College
- Incoming President and Chief Executive Officer, Dana-Farber Cancer Institute
- Lifang Hou, M.D., Ph.D.
- Associate Professor of Preventive Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine
- Neal Kassell, M.D.
- Chairman, Focused Ultrasound Foundation
- Professor of Neurosurgery, University of Virginia
- María Elena Martínez, Ph.D.
- Sam M. Walton Endowed Chair for Cancer Research, Professor of Family Medicine and Public Health, and Co-director of the Reducing :Cancer Disparities Program, UC San Diego Moores Cancer Center
- Deborah Mayer, Ph.D., R.N.
- Professor of Adult and Geriatric Health, University of North Carolina School of Nursing
- Director of Cancer Survivorship, UNC Lineberger Comprehensive Cancer Center
- Edith Mitchell, M.D., F.A.C.P
- Professor of Medical Oncology and Associate Director for Diversity Services, Sidney Kimmel Cancer Center at Thomas Jefferson University
- Augusto Ochoa, M.D.
- Professor of Pediatrics and Director, Stanley S. Scott Cancer Center, Louisiana State University
- Jennifer Pietenpol, Ph.D.
- Benjamin F. Byrd, Jr. Professor of Oncology, Professor of Biochemistry, and Director, Vanderbilt-Ingram Cancer Center
- Angel Pizarro, M.S.E.
- Technical Business Development Manager, Amazon Web Services Scientific Computing and Research Computing
- Barbara Rimer, Dr.P.H.
- Alumni Distinguished Professor and Dean, University of North Carolina Gillings School of Global Public Health
- Charles Sawyers, M.D.
- Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center
- Investigator, Howard Hughes Medical Institute
- Ellen Sigal, Ph.D.
- Founder and Chair, Friends of Cancer Research
- Patrick Soon-Shiong, M.D., FRCS (C), FACS
- Founder, Chair, and CEO, NantWorks LLC
- Wai-Kwan Alfred Yung, M.D.
- Professor of Neuro-Oncology and Chair of Clinical Cancer Care, University of Texas MD Anderson Cancer Center
- Ex Officio members of the Blue Ribbon Panel are:
- David Atkins, M.D., M.P.H.
- Acting Chief Research and Development Officer, Department of Veterans Affairs
- Robert Califf, M.D.
- Commissioner, U.S. Food and Drug Administration
- Karen Guice, M.D., M.P.P.
- Acting Assistant Secretary of Defense for Health Affairs, Department of Defense
- Jason Paragas, Ph.D.
- Director of Innovation, Lawrence Livermore National Laboratory
- Lawrence Tabak, D.D.S., Ph.D.
- Principal Deputy Director, National Institutes of Health
